While probiotics are often used to treat acute gastroenteritis (also known as infectious diarrhea) in children, the latest evidence shows no significant differences in outcomes, compared to a placebo. These results come from the large, double-blind, randomized controlled trial conducted at 10 geographically diverse U.S. pediatric emergency departments. Findings were published in the New England Journal of Medicine.
"This study presents the most robust evidence to date that use of probiotics does not improve outcomes of acute gastroenteritis in children, which calls into question current recommendations," says the author. "Recommendations to use probiotics for these patients were based on previous meta-analyses that have suggested probiotics may be beneficial, but the trials that were included had significant limitations. The rigor of our research design and our results warrant reconsideration of common practice."
Acute gastroenteritis, which can present with diarrhea, vomiting and abdominal pain, accounts for approximately 1.7 million visits to the emergency department and more than 70,000 hospitalizations per year in the U.S. It is the second leading cause of death worldwide in children younger than 5 years.
The study included 943 children, aged 3 months to 4 years of age. Two weeks after an emergency department visit for acute gastroenteritis, children in the study who received a five-day course of probiotic (Lactobacillus rhamnosus) fared no better than the placebo group in terms of illness severity, duration and frequency of diarrhea or vomiting, day-care absenteeism and rate of household transmission of the infection.
https://www.luriechildrens.org/en/news-stories/probiotic-no-better-than-placebo-for-acute-gastroenteritis-in-children/
https://www.nejm.org/doi/full/10.1056/NEJMoa1802597?query=featured_home
Latest News
Respiration key to increase oxygen in the brain
Eating within 10-hour window may help stave off diabetes, heart disease
Engineering better broadly neutralizing HIV antibodies
Targeting gene network to treat autism and intellectual disability
Compound controls biological clock with light
Other Top Stories
Protein synthesis from non-traditional start site!
Why women with many children show evidence of accelerated aging?
Undruggable target now made druggable!
Apoptosis spreads through perpetuating waves!
New understanding on cell signaling complex
Protocols
Dual-Angle Protocol for Doppler Optical Coherence Tomography to Improve Retinal Blood Flow Measur…
Detection of protein SUMOylation in vivo
In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induce…
Determination of SUMOylation sites
miR-Selection 3'UTR Target Selection Kit
Publications
Cerebral oxygenation during locomotion is modulated by respiration
Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patient…
Controlling the Circadian Clock with High Temporal Resolution through Photodosing
Phosphorylation of Npas4 by MAPK Regulates Reward-Related Gene Expression and Behaviors
Phosphorylation of Npas4 by MAPK Regulates Reward-Related Gene Expression and Behaviors
Presentations
Hypoxia Inducible Factor - 1 (HIF-1)
Intracellular Protein Degradation
Pathophysiology of Type 1 Diabetes
Plant Viruses
Regulation by changes in chromatin structure
Posters
AACC-2018-Infectious Disease
AACC-2018-Mass Spectrometry Applications
AACC-2018-Lipids/Lipoproteins
AACC-2018-Management
AACC-2018-Immunology-abstracts